Keyphrases
Programmed Death-ligand 1 (PD-L1)
100%
Myelodysplastic Syndrome
100%
Systems Immunology
100%
Melanoma Patients
100%
Mass Cytometry
100%
Anti-programmed Cell death-1 Therapy
100%
Myeloid Cells
66%
Checkpoint Inhibitor Therapy
66%
Myeloid Blasts
66%
Cytomics
66%
Malignancy
33%
T Cells
33%
Clinical Significance
33%
Peripheral Blood Mononuclear Cells
33%
Immunophenotyping
33%
Melanocytic Tumor
33%
Advanced Melanoma
33%
Refractory Anemia with Excess Blasts
33%
Start of Treatment
33%
Bone Marrow Biopsy
33%
Phenotype Evolution
33%
Medicine and Dentistry
Myelodysplastic Syndrome
100%
Melanoma
100%
Immunology
100%
Programmed Cell Death
100%
Mass Cytometry
75%
Myeloid Cell
50%
Neoplasm
25%
Bone Marrow Biopsy
25%
Refractory Anemia with Excess of Blasts
25%
Medicine
25%
Cancer
25%
T Cell
25%
Clinical Significance
25%
Immunophenotyping
25%
Peripheral Blood Mononuclear Cell
25%
Immunology and Microbiology
Immunology
100%
Myeloid
100%
Programmed Cell Death 1
100%
Mass Cytometry
60%
T Cell
20%
Peripheral Blood Mononuclear Cell
20%